Evidence map›Paper›PMID 23963123›Full record

Observational studyCritical care medicine2013

Role of diabetes in the development of acute respiratory distress syndrome.

Shun Yu, David C Christiani, B Taylor Thompson, Ednan K Bajwa, Michelle Ng Gong

Open access · greenAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Critical care medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Disruption of immune responses by type 1 diabetes exacerbates SARS-CoV-2 mediated lung injury.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Total flavonoids ofIranian journal of basic medical sciences · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shun Yu1Division of Critical Care Medicine, Department of Medicine, Jay B. Langner Critical Care Service, Montefiore Medical Center, Bronx, NY. 2Pulmonary and Critical Care Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA. 3Environmental Health Department, Environmental and Occupational Medicine and Epidemiology Program, Harvard School of Public Health, Boston, MA. 4Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY.
David C Christiani
B Taylor Thompson
Ednan K Bajwa
Michelle Ng Gong
Massachusetts General Hospital · USAlbert Einstein College of Medicine · US

Funding

Translational Research Support CoreP30ES000002 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI SUSAN A KORRICK · 1985 to 2026
$44.6M
MOLECULAR EPIDEMIOLOGY OF ARDSR01HL060710 · NHLBI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2000 to 2015
$8.4M
LIPS-A: Lung Injury Prevention Study with AspirinU01HL108712 · NHLBI · MAYO CLINIC ROCHESTER · PI GAJIC, OGNJEN, GONG, MICHELLE NG · 2011 to 2013
$6.1M
Early Insulin Therapy and Development of ARDSR01HL086667 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GONG, MICHELLE NG · 2007 to 2011
$2.2M
NHLBI NIH HHS R01 HL060710NHLBI NIH HHS R01 HL086667NHLBI NIH HHS U01 HL108712NIEHS NIH HHS P30 ES000002
6 · The paper itself

Abstract

objectivesDiabetes has been associated with decreased development of acute respiratory distress syndrome in some, but not all, previous studies. Therefore, we examined the relationship between diabetes and development of acute respiratory distress syndrome and whether this association was modified by type of diabetes, etiology of acute respiratory distress syndrome, diabetes medications, or other potential confounders.

designObservational prospective multicenter study.

settingFour adult ICUs at two tertiary academic medical centers. PATIENTS: Three thousand eight hundred sixty critically ill patients at risk for acute respiratory distress syndrome from sepsis, pneumonia, trauma, aspiration, or massive transfusion.

interventionsNone. MEASUREMENTS AND MAIN

resultsDiabetes history was present in 25.8% of patients. Diabetes was associated with lower rates of developing acute respiratory distress syndrome on univariate (odds ratio, 0.79; 95% CI, 0.66-0.94) and multivariate analysis (adjusted odds ratio, 0.76; 95% CI, 0.61-0.95). After including diabetes medications into the model, diabetes remained protective (adjusted odds ratio, 0.75; 95% CI, 0.59-0.94). Diabetes was associated with decreased development of acute respiratory distress syndrome both in the subgroup of patients with sepsis (adjusted odds ratio, 0.77; 95% CI, 0.61-0.97) and patients with noninfectious etiologies (adjusted odds ratio, 0.30; 95% CI, 0.10-0.90). The protective effect of diabetes on acute respiratory distress syndrome development is not clearly restricted to either type 1 (adjusted odds ratio, 0.50; 95% CI, 0.26-0.99; p = 0.046) or type 2 (adjusted odds ratio, 0.77; 95% CI, 0.60-1.00; p = 0.050) diabetes. Among patients in whom acute respiratory distress syndrome developed, diabetes was not associated with 60-day mortality on univariate (odds ratio, 1.11; 95% CI, 0.80-1.52) or multivariate analysis (adjusted odds ratio, 0.81; 95% CI, 0.56-1.18).

conclusionsDiabetes is associated with a lower rate of acute respiratory distress syndrome development, and this relationship remained after adjusting for clinical differences between diabetics and nondiabetics, such as obesity, acute hyperglycemia, and diabetes-associated medications. In addition, this association was present for type 1 and 2 diabetics and in all subgroups of at-risk patients.

Indexed as

AdultAgedDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2FemaleHumansHyperglycemiaHypoglycemic AgentsMaleMiddle AgedPneumoniaPrevalenceProspective StudiesRespiratory AspirationRespiratory Distress SyndromeRisk FactorsHypoglycemic Agents

Identifiers

PMID23963123
PMCPMC4007199
OpenAlexW2074552958

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.